9th December 2025
Psychotropic Drug Directory
This update contains changes to 23 records. 3.7 Old age…


Psychotropic Drug Directory supports the optimal and rational use of medicines, to improve the quality of life for people with mental health needs.
Close
Close

Contact our team to see how our services can directly help you.
Close

For new and experienced users, get the most out of your access to MedicinesComplete with our handy tips and shortcuts. Save time and get to the information you need quickly.
Close

Register for this webinar to learn how MedicinesComplete can support you in implementing effective processes to reduce medication errors and improve patient safety.
Close

Here’s a handy reminder of all the patient safety topics we’ve covered.
Close



Essential knowledge to help you make the right decision.
MedicinesComplete makes it easy for health and care professionals to access trusted evidence-based guidance to support confident decision making at the point of need.
Use this page for information, training, and guides to help you get the most out of your access to this trusted online platform.

Esbonia’r canllaw defnyddiwr hwn sut i gyrchu a llywio MedicinesComplete, ynghyd â chynnig
canllawiau ar sut i ddefnyddio cyhoeddiadau penodol.
MedicinesComplete brings together trusted knowledge products providing medicines information and expert guidance on the safe use and administration of drugs and medicines, in one place.








Our knowledge products are regularly updated online through MedicinesComplete
9th December 2025
This update contains changes to 23 records. 3.7 Old age…
9th December 2025
This update contains changes to 23 records.
3.7 Old age has been revised and its name has been changed to 3.7 Older adults. A new record, 6.11
Weight gain, has been added to Management of side-effects, and
consequently 6.11 Others has been renamed 6.12 Others, side-effects.
Updates were also made to 1.4 Alcohol dependence and abuse, 1.13
Dementias, 1.14 Depression, and 1.15 Eating disorders to incorporate
literature on GLP-1 agonists; to 1.21 Psychosis and schizophrenia to add
literature on a new product recently licensed in the US; and to 3.9
Perinatal to include the latest MHRA drug safety information. Chapter 7
has also been updated with discontinued and relaunched products.
New: 6.11 Weight gain
Revisions: 3.7 Older adults
Minor updates: 1.4 Alcohol dependence and abuse; 1.13 Dementias;
1.14 Depression; 1.15 Eating disorders; 1.16 Insomnia; 1.21 Psychosis and
schizophrenia; 2.1.1 Hypnotics – relative side-effects; 2.1.2
Antidepressants – relative side-effects; 2.1.3 Antidepressants –
pharmacokinetics and receptor effects; 2.1.4 Antipsychotics – relative side-
effects; 2.1.5 Antipsychotics – pharmacokinetics and receptor effects;
2.1.6 Anxiolytics – relative side-effects; 3.2 Cardiovascular (CV) disease;
3.8 Parkinson’s disease (PD); 3.9 Perinatal; 3.10 Renal impairment; 4.1.1
Benzodiazepines; 6.5 Dermatological effects, 6.6 Endocrine effects; 6.12
Others, side-effects; 7.0 Psychotropic drugs.
9th December 2025
For December, 340 new interactions have been added, and 347…
9th December 2025
For December, 340 new interactions have been added, and 347 existing interactions have been updated.
9th December 2025
This update contains major revisions to the Hospital Toxicology chapter,…
9th December 2025
9th December 2025
This update contains 9 new drugs, 31 minor updates, and…
9th December 2025
This update contains 9 new drugs, 31 minor updates, and 162 new or updated pieces of short management advice. In addition, 16 existing drugs have been revalidated.
9th December 2025
This update contains 5 new monographs and 5 revised monographs….
9th December 2025
This update contains 5 new monographs and 5 revised monographs.
New monographs: Carfilzomib; Ceftobiprole medocaril sodium; Eculizumab; Nivolumab; Rezafungin.
Revised monographs: Ampicillin; Infliximab; Ketamine; Rituximab; Tigecycline.
9th December 2025
This update contains 2 revised monographs. The following monographs have…
9th December 2025
This update contains 2 revised monographs.
The following monographs have been fully revised: Inhaled corticosteroids, Inhaled long-acting beta2 agonists (LABAs).
The following monographs have been partially
updated: Bronchodilators, Ipratropium bromide, Salbutamol, Theophylline, Tiotropium.

Stay updated on the latest new drugs and significant changes to medicines information on MedicinesComplete when you sign up to our monthly newsletter.

For deeper information about essential knowledge products on MedicinesComplete browse our library of on-demand webinars featuring our expert editorial team, or register for our latest live webinar.

![]()
Facilitates the exchange of information between colleagues on matters relating to drug and symptom control, non-drug and service issues in palliative and hospice care. Register to take part today.

For support, to provide feedback on our content, suggest ideas for new content, or for any other enquiry please get in touch.

If you are interested in creating or contributing to our content on MedicinesComplete please use the link below to find out more.